Office of Inspector General (United States)

Performant Awarded HHS OIG IDIQ Contract for Medical Review and Consultative Services

Retrieved on: 
Tuesday, February 8, 2022
Technology, Insurance, Finance, Consulting, Accounting, Professional Services, Software, Managed Care, Health, Data Management, Policy, Industry, Office of Inspector General, U.S. Department of Health and Human Services, Fraud, Part, Government, IDIQ, Medicare, OIG, Solution, Company, SVP, Office of Inspector General (United States), Pay for performance (healthcare), HHS OIG, HHS, FFS, Nasdaq, Partnership, Health insurance, Medicaid

Performant Financial Corporation (Nasdaq: PFMT) (Performant, the Company), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that on January 4, 2022, the U.S. Department of Health and Human Services, Office of the Inspector General (HHS OIG) awarded Performant the indefinite delivery, indefinite quantity (IDIQ) contract, with a base term of one year and four additional 1-year options, to provide medical review and consultative services.

Key Points: 
  • Performant Financial Corporation (Nasdaq: PFMT) (Performant, the Company), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today that on January 4, 2022, the U.S. Department of Health and Human Services, Office of the Inspector General (HHS OIG) awarded Performant the indefinite delivery, indefinite quantity (IDIQ) contract, with a base term of one year and four additional 1-year options, to provide medical review and consultative services.
  • Under this national IDIQ contract, Performant will provide medical review and consultative services associated with the oversight activities of the OIG, primarily assessing services and claims for Medicare fee-for-service (FFS) payments for Part A and Part B. OIG may also utilize Performants services to assess services and claims for Medicaid or the Medicare Prescription Drug Plan (Part D).
  • In addition to medical review of selected claims, Performant will provide support for auditee discussions or secondary reviews to assist HHS OIG in pursuing greater policy adherence, identifying improper payment vulnerabilities, and refining future industry communications and training.
  • Performant has been providing recovery audit services for more than nine years to both commercial and government clients.

Mobile App Improves Treatment Adherence Success in Patients, Groundbreaking Tech Study Finds

Retrieved on: 
Thursday, February 3, 2022
CEO, Chiropractic, Patient, Technology, Office of Inspector General (United States), Population, JMIR, Industry, Reward, Private practice, Digital, Review, Healthcare, Health insurance, Medical device

Improving healthcare through technology, Kaizenovate developed the Kanvas App to support patients in their adherence to chiropractic and physiotherapy treatment plans.

Key Points: 
  • Improving healthcare through technology, Kaizenovate developed the Kanvas App to support patients in their adherence to chiropractic and physiotherapy treatment plans.
  • "Historical evidence suggests that two-thirds of patients involved in treatment programs including physiotherapy are not adherent with their prescribed treatment plans.
  • But now, we've proven that the use of a mobile app can have a transformative impact on adherence.
  • The study compared adherence to prescribed physical health treatment among more than 4,000 patients attending multiple chiropractic rehabilitation clinics who did and did not choose to adopt a mobile app to complement their treatment.

Mike Castle Joins Board at A Better Delaware

Retrieved on: 
Tuesday, January 18, 2022
ABD, Education, Office of Inspector General (United States), Rain, House, Maharashtra Legislative Assembly, The News Journal, Human, Linear code, Advisory board, Jewish Labor Committee, Facebook, Public policy, News, Founder, Louisiana House of Representatives, Environment, Congress, Multimedia, Representative, State government, General assembly, Board, Management, Public relations

Chris Kenny, Chairman and Founder of A Better Delaware announced the addition of Castle to the board this past Thursday.

Key Points: 
  • Chris Kenny, Chairman and Founder of A Better Delaware announced the addition of Castle to the board this past Thursday.
  • "A Better Delaware has established itself as a leading mainstream voice for taxpayer accountability and good governance," said Castle.
  • "Mike Castle shares our passion to advocate with and for the citizens of Delaware," said Kathleen Rutherford, Executive Director for A Better Delaware.
  • A BETTER DELAWARE: A Better Delaware is a non-partisan public policy and political advocacy organization that supports pro-growth, pro-jobs policies and greater transparency and accountability in state government.

Excella to Expand Work with U.S. Department of Health and Human Services (HHS) in the Office of the Inspector General’s (OIG’s) Chief Data Office

Retrieved on: 
Tuesday, December 7, 2021
Data Management, Health, Security, Technology, Other Technology, Other Health, Software, Solution, ERI, Technology, Office of Inspector General, U.S. Department of Health and Human Services, Thought, OCDO, Organization, HHS, Alaska Federal Health Care Access Network, Partnership, Fraud, Program, Abuse, HHS OIG, AI, OIG, Office of Inspector General (United States), Communication, Management, Pharmaceutical industry

HHS OIG oversees more than $1 trillion in funding that directly impacts citizens everyday lives.

Key Points: 
  • HHS OIG oversees more than $1 trillion in funding that directly impacts citizens everyday lives.
  • The OCDO empowers OIG to use data proactively and has become the model for using data to fight fraud, waste, and abuse and improve program effectiveness.
  • Combatting fraud, waste, and abuse with our federal agency partners is a passion for our team at Excella.
  • Since 2002, federal agencies, prominent brands, and trailblazing non-profits have turned to Excella to transform bold ideas into elegant technology solutions.

Otsuka Responds to the Office of Inspector General’s Favorable Opinion Regarding its Hospital Free Trial Program of Long-Acting Injectable for Inpatient Schizophrenia Treatment

Retrieved on: 
Wednesday, November 17, 2021
Biotechnology, Mental Health, Hospitals, Health, Pharmaceutical, OIG, Compliance, Maintenance, OAPI, Office of Inspector General (United States), Health, Commercialization, Heart, Department, Doctor of Philosophy, Lists of diseases, Bipolar I disorder, Creativity, United States Department of Health and Human Services, Medicine, Cardiology, Schizophrenia, LLC, Twitter, Mental health, Development, LAI, LinkedIn, Ōtsuka, Solution, HHS, Tuberculosis, Nephrology, Suicide, Patient, Pharmaceutical industry

Such programs are designed to improve medication adherence and clinical outcomes for a vulnerable patient population.

Key Points: 
  • Such programs are designed to improve medication adherence and clinical outcomes for a vulnerable patient population.
  • This favorable opinion by OIG of Otsukas program is important because it will increase the treatment options available to hospital providers and their patients.
  • This opinion validates Otsukas program design and our commitment to identifying solutions that keep the patient at the center of everything we do.
  • Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: Otsukapeople creating new products for better health worldwide.

AirAvant Medical and First Nation Group join forces to distribute revolutionary sleep apnea device to Veterans and active-duty military members nationwide.

Retrieved on: 
Tuesday, November 2, 2021
Dementia, Sleep, Degenerative disease, Travel, Industry, Hypertension, TAA, Continuous positive airway pressure, Service-Disabled Veteran-Owned Small Business, Small business, COPD, Partnership, Obstructive sleep apnea, Patient, FDA, Snoring, Federation, United States Department of Veterans Affairs, United States Department of Defense, CPAP, Senior, Marketing, Stroke, Diabetes, Health, Solution, Unitary state, Department, Mark (given name), OSA, Office of Inspector General (United States), Business development, DBA, Sleep apnea, Health insurance, Pharmaceutical industry, Medical device

"This partnership reaffirms First Nation Group's commitment to offer clinicians treatment options to meet the varied needs of Veterans with obstructive sleep apnea."

Key Points: 
  • "This partnership reaffirms First Nation Group's commitment to offer clinicians treatment options to meet the varied needs of Veterans with obstructive sleep apnea."
  • AirAvant Medical, which develops and markets innovative respiratory medical devices, recently introduced Bongo Rx to the $3.7 billion global sleep apnea devices market.
  • This innovative device is clinically proven to treat mild to moderate sleep apnea, including snoring, caused by blocked air passages.
  • "The opportunity to proudly serve Veterans also attracted AirAvant Medical to the partnership," said AirAvant co-President and co-founder Bruce Sher.

Taro Provides Results for September 30, 2021

Retrieved on: 
Thursday, October 28, 2021
General Health, Pharmaceutical, Health, Cream, Interest, Industry, Mission statement, Rule, Private Securities Litigation Reform Act, FDA, U.S. Department of Defense Strategy for Operating in Cyberspace, Share repurchase, NYSE, Food, Abbreviated New Drug Application, SEC, Language, Time, Regulation of tobacco by the U.S. Food and Drug Administration, Income, Forward-looking statement, Marketing, Company, Board, U.S. Department of Justice Office of Legislative Affairs, Environment, Program, Research, DOJ, Office of Inspector General, U.S. Department of Health and Human Services, Taro, Office of Inspector General (United States), Board of directors, Pharmaceutical industry, Animal, Fine chemical, Reinsurance, Insurance, Bank, Audit

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro or the Company) today provided unaudited financial results for the quarter and six months ended September 30, 2021.

Key Points: 
  • Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro or the Company) today provided unaudited financial results for the quarter and six months ended September 30, 2021.
  • Quarter ended September 30, 2021 Highlights compared to September 30, 2020
    Net sales of $132.0 million decreased $10.9 million.
  • Net income attributable to Taro was $23.3 million compared to $45.1 million, resulting in diluted earnings per share of $0.62 compared to $1.18.
  • Six Months ended September 30, 2021 Highlights compared to September 30, 2020
    Net sales of $279.1 million increased $18.6 million.

On Child Health Day, New Focus on Grandparents as Caregivers

Retrieved on: 
Monday, October 4, 2021
Research, Congress, Health, Grandparent, Multimedia, Pregnancy, Family Matters, Biology, Office of Inspector General (United States), Public health, Dietary Guidelines for Americans, National, Child, Rise, Love, Lactation, USDA, Risk, Pediatric nursing, Brain, Conditional sentence, Birth control, Dietary supplement, Soft drink

With more grandparents caring for grandchildren and continued research demonstrating the power of the earliest years for children's future health and well-being, public health and child nutrition groups are providing additional resources and support for grandfamilies.

Key Points: 
  • With more grandparents caring for grandchildren and continued research demonstrating the power of the earliest years for children's future health and well-being, public health and child nutrition groups are providing additional resources and support for grandfamilies.
  • According to DietaryGuidelines.gov, this edition also emphasizes that it is never too early or too late to eat healthy.
  • In particular, infancy and toddlerhood provide an important opportunity to build long-lasting healthy habits, including a healthy beverage pattern.
  • Child Health Day became a national day of observance in 1928 when President Calvin Coolidge proclaimed the day at the request of Congress.

Omni Closes its $2mm Private Token Sale, 10x Oversubscribed, Adds Advisory Team, & Plans Apollo-X IDO & Trading on PancakeSwap on July 16th

Retrieved on: 
Thursday, July 15, 2021
Deities, Gods, Omni, Apollo, Ido, Ice

OMNI will be the 1st IDO launch in history on Apollo-X's revolutionary new Initial Dex Offering Platform.

Key Points: 
  • OMNI will be the 1st IDO launch in history on Apollo-X's revolutionary new Initial Dex Offering Platform.
  • We look forward to an exciting IDO on the PAID Network's Apollo-X platform , the first ever of its kind."
  • Petrix Barbosa , OMNI's Chief Development Officer also states, "Omni intends to be a driving source of inspiration-based wealth internationally.
  • We intend to embrace this movement, create positive societal reform, and raise the bar for social media apps' responsibility to the world."